Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$59.4K
5.82K shares
What this filing means
KAISER PETER plans to sell 5.82K shares of OCULAR THERAPEUTIX, INC valued at approximately $59.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001950047-26-001631
Officer· Chief Development Officer
Since Feb 2026
5.82K
Shares to sell
$59.4K
Approx. market value
2.81K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/22/2026
2.81KTotal acquired2.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2026 | Restricted stock vesting under a registered plan Not Applicable | 2.81K | — |
| Total | 2.81K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.01K
Market value
$36.2K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.81K
Market value
$23.3K
2/23/2026
Total
Units
5.82K
Value
$59.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/24/2025 | 3.01K | $36.2K | — | Completed |
| Planned — Approximate Date | ||||
2/23/2026 | 2.81K | $23.3K | NASDAQ | Planned |
| Total | 5.82K | $59.4K | ||